SUNNYVALE, Calif., Jan. 18,
2023 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) will report financial results for
the second quarter of fiscal year 2023, ended December 31,
2022, after the market close on February 1, 2023. Management
will host a conference call to review the results at 1:30 p.m.
PT / 4:30 p.m. ET on the same day.
The conference call dial-in numbers are (833) 316-0563
(USA) or (412) 317-5747
(international). In addition, a dial up replay of the conference
call will be available approximately one hour after the call's
conclusion for one week. The replay number is (877) 344-7529
(USA), or (412) 317-0088
(international), conference ID: 3831878.
A live webcast of the call will also be available from the
Investor Relations section of the company's website
at investors.accuray.com. A webcast replay can be accessed on
the website and will remain available
until Accuray announces its results for the third quarter
of fiscal 2023.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions that are designed to deliver
radiation treatments for even the most complex cases—while making
commonly treatable cases even easier—to meet the full spectrum of
patient needs. We are dedicated to continuous innovation in
radiation therapy for oncology, neuro-radiosurgery, and beyond, as
we partner with clinicians and administrators, empowering them to
help patients get back to their lives, faster. Accuray is
headquartered in Sunnyvale, California, with facilities worldwide. To
learn more, visit www.accuray.com or follow us
on Facebook, LinkedIn, Twitter,
and YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2023-financial-results-on-february-1-2023-301724509.html
SOURCE Accuray Incorporated